Anti-human influenza virus antibody
AssigneeTakara Shuzo Co., Ltd.
InventorsYoshinobu Okuno, Yuji Isegawa, Fuyoko Sasao, Shigeharu Ueda
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakara Shuzo Co., Ltd.
InventorsYoshinobu Okuno, Yuji Isegawa, Fuyoko Sasao, Shigeharu Ueda
Estimating the term…
An anti-human influenza virus antibody is provided which recognizes the stem regions of haemagglutinin molecules of the H1N1 and H2N2 subtypes and has a neutralization activity, but does not recognize the stem region of the H3N2 subtype and has no neutralization activity. Also provided is an immunogenic artificial polypeptide having an antigenicity substantially the same as the stem regions of haemagglutinin molecules. Provided further is an immunogenic artificial polypeptide having an antigenicity substantially the same as the stem regions of haemagglutinin molecule and lacking the globular head region of haemagglutinin molecules. The antibody is useful in the diagnosis and treatment of influenza A virus, while the polypeptides are useful as a vaccine.
An anti-human influenza virus antibody having the following characteristics:
The hybridoma deposited as FERM BP-4517.
Dependencies are inferred from the claim text.